I recently bought health insurance for few family members. The kind of person I'm, this meant an uncontrollable spiral into research
I read through at-least
- 15 policy documents,
- handbooks+circulars published by IRDAI (the regulatory authority),
- and several blogs
**10 things to remember while buying health insurance**
Now the fun part
The room rent across major Insurers is generally capped to 1% of Sum Insured(SI) per day; which means if your SI is 5 lakh, the insurer WON'T pay more than 5k/day
ICU room charges are generally capped to 2% of SI; which means if your SI is 5 lakh, the insurer will NOT pay more than 10k/day
If you have had experience with ICU charges, 10k/day is nothing for ICU
Say you have a SI of 5 lakh, and you had opted for a room within admissible range (5k/day)
Imagine on the day of discharge, you are presented with the final bill as shown
Each of the line items gets reduced in "proportion" of (5/8) = (admissible/actual room rent)
Tragic and funny
You need to be very careful about Co-pay especially if you are buying Insurance for Senior citizens, or folks with critical illness
What that means is, if your admissible claim amount is say 3 lakh, for a Co-pay of 10%, you will have to put up 30k; if claim amount is 5 lakh, you will have to put up 50k. You get the idea
Unfortunate as it is, when she buys an insurance, she CAN'T claim any costs towards hospitalisations@Diabetes till she has waited for at-least
Also, the waiting period differs across diseases & Insurers
**What I did - I looked for a policy that gave me 2 years as waiting period; most insurers give a standard 4 year waiting period
**Make a list of all the pre-existing diseases(PED)/critical diseases specific to the person being insured and factor in the waiting period for those specific diseases
This means, the day I exit my org, the policy expires. Worst, the reverse countdown that had started on my waiting period gets reset!
Fortunately, there's an easy way to tackle this
**Porting - Moving to a new Insurer
Migration - Moving to a new policy within the same Insurer
So say for a family of 3 (1 kid, husband and wife), the total SI could be 5 lakh, which can be claimed by any of the 3 members
On demise of the primary policyholder, the policy ceases to exist for all other members, and they have to buy a new policy at the existing market rates
Many Insurers reward you a 5% CB for every claim free year though I did see policies going as high as 25%
% of CB is important if you are buying insurance early on and also if you are fit. Why?
Say you have an individual insurance with cover of 5 lakh. If you get hospitalised for a medical emergency, and your total expense was 8 lakh, you will have to pay...
Now say everything remains the same, in addition, you also had a top-up policy with a deductible of 5 lakh.
This time, the remaining 3 lakh (claim amount above deductible) will be covered by your top-up policy
ALWAYS go for policies that have "cashless" mode & ALWAYS check for hospitals around you that are included in the PPN.
You May Also Like
@EricTopol @NBA @StephenKissler @yhgrad B.1.1.7 reveals clearly that SARS-CoV-2 is reverting to its original pre-outbreak condition, i.e. adapted to transgenic hACE2 mice (either Baric's BALB/c ones or others used at WIV labs during chimeric bat coronavirus experiments aimed at developing a pan betacoronavirus vaccine)
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj
@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj
@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o